[HTML][HTML] Five-year outcomes of patients enrolled in the REVEAL Registry
HW Farber, DP Miller, AD Poms, DB Badesch, AE Frost… - Chest, 2015 - Elsevier
BACKGROUND Pulmonary arterial hypertension (PAH) is a rare, severe disease
characterized by worsening right-sided heart failure, decreasing functional status, and poor
survival. The present study characterizes the 5-year survival in the United States of a new
and previous diagnosis of PAH in patients stratified by baseline functional class (FC). The
Registry to Evaluate Early and Long-term PAH Disease Management (REVEAL Registry) is
a 55-center observational US registry of the demographics, disease course, and …
characterized by worsening right-sided heart failure, decreasing functional status, and poor
survival. The present study characterizes the 5-year survival in the United States of a new
and previous diagnosis of PAH in patients stratified by baseline functional class (FC). The
Registry to Evaluate Early and Long-term PAH Disease Management (REVEAL Registry) is
a 55-center observational US registry of the demographics, disease course, and …